HIV-free survival among nine- to 24-month-old children born to HIV-positive mothers in the Rwandan national PMTCT programme: a community-based household survey

Table 5 Factors associated with HIV-free survival among HIV-exposed infants, Rwanda PMTCT programme, 2009

	HIV-free survival
	Adjusted odds ratio	95% CI
ARV and/or cotrimoxazole taken by the mother
None	Reference	1
Cotrimoxazole	0.9	0.5-1.5
NVP alone	1.5	0.8-2.7
Dual therapy	0.6	0.3-1.5
Triple therapy	0.6	0.3-1.07
Location
Rural	Reference	1
Urban	0.7	0.3-1.2
Membership of a PLHIV association, (n = 1417)
No	Reference	1
Yes	0.7	0.4-0.995